IP Library › Granted Patent US 8,987,214
Granted Patent B2
US 8,987,214 · App. 14/507,267 · Granted Mar 24, 2015

Solid compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,987,214
App. No.
14/507,267
Granted
Mar 24, 2015
Kind
B2
Abstract

The present invention features solid compositions comprising a selected HCV inhibitor in an amorphous form. In one embodiment, the selected HCV inhibitor is formulated in an amorphous solid dispersion which comprises a pharmaceutically acceptable hydrophilic polymer and preferably a pharmaceutically acceptable surfactant.

Claims (3)

1. A solid oral dosage form comprising a solid solution which includes:

copovidone, and

optionally a pharmaceutically acceptable surfactant.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2015
From: GAO, YI; ZHANG, GEOFF
To: ABBVIE INC.
Reel/Frame 034802/0666 →